During the past decade, St. Thomas Research Institute conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 9 clinical trials were completed, i.e. on average, 112.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Thomas Research Institute" #1 sponsor was "Boston Scientific Corporation" with 5 trials, followed by "Medtronic" with 5 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 5 trials sponsored, "Northwest Biotherapeutics" with 2 trials sponsored and "Angel Medical Systems" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Thomas Research Institute" #1 collaborator was "Alberta Innovation and Science" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "GE Healthcare" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator and "Medtronic Bakken Research Center" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "St. Thomas Research Institute" are "Heart Failure" (6 trials), "Atrial Fibrillation" (4 trials), "GBM" (2 trials), "Glioblastoma Multiforme" (2 trials) and "Stroke" (2 trials). Many other conditions were trialed in "St. Thomas Research Institute" in a lesser frequency.

Most popular intervention types in "St. Thomas Research Institute" are "Device" (17 trials), "Drug" (5 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Warfarin" (2 trials), "Anti-coagulation therapy" (1 trials), "Anti-platelet therapy" (1 trials), "Cardiac Resynchronization Therapy - MPP" (1 trials) and "DCVax-L" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Thomas Research Institute" are 22 trials for "All" genders.

Currently, there are NaN active trials in "St. Thomas Research Institute". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in St. Thomas Research Institute, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in St. Thomas Research Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".